NDC 0121-0775 – Guaifenesin and Codeine Phosphate
Guaifenesin 100 mg/5mL; Codeine Phosphate 10 mg/5mL · Solution · Oral
Product NDC0121-0775
Product details
- Brand name
- Guaifenesin and Codeine Phosphate
- Generic name
- Guaifenesin and Codeine Phosphate
- Labeler
- PAI Holdings, LLC
- Dosage form
- Solution
- Route
- Oral
- Marketing category
- OTC MONOGRAPH DRUG · M012
- Marketed since
- October 1, 2006
- Listing expires
- December 31, 2026
- Pharmacologic class
- Expectorant; Opioid Agonist
Active ingredients
- Guaifenesin 100 mg/5mL
- Codeine Phosphate 10 mg/5mL
Uses, dosage, side effects and warnings for Guaifenesin and Codeine Phosphate →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0121-0775-04 | 118 mL in 1 BOTTLE (0121-0775-04) | Oct 1, 2006 |
| 0121-0775-16 | 473 mL in 1 BOTTLE (0121-0775-16) | Oct 1, 2006 |
Recalls mentioning this NDC
- D-0222-2025 Feb 12, 2025 · Class III
Superpotent; sodium benzoate preservative
Other Guaifenesin and Codeine Phosphate products
- 50090-1428 Guaifenesin 100 mg/5mL; Codeine Phosphate 10 mg/5mL · Solution · A-S Medication Solutions
- 55154-5791 Codeine Phosphate 10 mg/5mL; Guaifenesin 100 mg/5mL · Solution · Cardinal Health 107, LLC
- 0121-1550 Guaifenesin 200 mg/10mL; Codeine Phosphate 20 mg/10mL · Solution · PAI Holdings, LLC
- 0121-1775 Guaifenesin 100 mg/5mL; Codeine Phosphate 10 mg/5mL · Solution · PAI Holdings, LLC
- 68788-8361 Guaifenesin 100 mg/5mL; Codeine Phosphate 10 mg/5mL · Solution · Preferred Pharmaceuticals Inc.